David M. Jablons, MD - Cardiothoracic Surgery. Dr. Jablons is certified by the American Board of Surgery and American Board of Thoracic Surgery. His special interest is in molecular biology of lung cancer and he is a leading expert in surgical therapy for malignant pleural mesothelioma.

Dr. Hedy Lee Kindler is the Director of the Mesothelioma Program at the University of Chicago. She is an Assistant Professor of Medicine in the Section of Hematology/Oncology and a Member of the Cancer Research Center. Dr. Kindler is an internationally recognized expert in new drug development for mesothelioma. She chairs the Mesothelioma Program of the Cancer and Leukemia Group B, a national cooperative cancer research group.

We are the Center for Surgical Oncology at the Washington Cancer Institute, Washington Hospital Center, in Washington, D.C. We specialize in the surgical treatment of cancers that arise in the gastrointestinal tract (stomach cancer, appendix cancer, and colorectal cancer); and other areas of the abdomen and pelvis. Our advanced services include specialty treatment programs for gastric cancer, pseudomyxoma peritonei, peritoneal carcinomatosis (cancers that have spread to the intraabdominal surfaces), hepatobiliary (primary and metastatic liver cancer), pancreas cancer, as well as primary peritoneal surface malignancies such as peritoneal mesothelioma and abdominopelvic sarcoma.

I am a surgeon who specializes in treating patients with cancers of the lung, esophagus, mediastinum, and chest wall, and those with mesothelioma. My research efforts focus on the genetics of lung cancer and mesothelioma, in an effort to predict how a patient will respond to a particular treatment, and on the development of methods to detect thoracic cancers at an early stage. I have also been a leader in national clinical trials for the treatment of thoracic cancers.